filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes to the risk factors as previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(dollars in thousands, except per share data)
We had two share repurchase authorizations outstanding during the quarter ended June 30, 2022. On February 16, 2022 and May 4, 2022, we publicly announced that our Board of Directors authorized the repurchase of our outstanding common stock in one or more open market and/or privately negotiated transactions, up to an aggregate of $500,000 per authorization. The repurchase authorizations do not have expiration dates. We repurchased the following shares of our common stock during the second quarter of 2022:
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||||
| April 1 - 30, 2022 | 25,870 | $ | 4,503.35 | 25,870 | $ | 142,753 | ||||||||||||||||||||
| May 1 - 31, 2022 | 24,119 | $ | 4,311.45 | 24,119 | $ | 538,765 | ||||||||||||||||||||
| June 1 - 30, 2022 (1) | 11,089 | $ | 4,186.59 | 11,089 | $ | 492,340 | ||||||||||||||||||||
| Total | 61,078 | $ | 4,370.06 | 61,078 |
(1) Of the 11,089 shares repurchased in June 2022, 9,192 outstanding shares were repurchased under the February authorization, and the remaining 1,897 outstanding shares were repurchased under the May authorization. The February authorization has been fully utilized as of June 30, 2022.
On August 3, 2022, the Board of Directors approved an additional repurchase authorization of up to an aggregate of $500,000. The repurchase authorization does not have an expiration date.
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits